Global gene expression profiling in PPAR-γ agonist-treated kidneys in an orthologous rat model of human autosomal recessive polycystic kidney disease

PPAR Research

Volumn , Issue , 2012, Pages

  Yoshihara, Daisuke ^a   Kugita, Masanori ^a   Yamaguchi, Tamio ^a,b   Aukema, Harold M ^b   Kurahashi, Hiroki ^a   Morita, Miwa ^a   Hiki, Yoshiyuki ^a   Calvet, James P ^c   Wallace, Darren P ^c   Toyohara, Takafumi ^d   Abe, Takaaki ^d   Nagao, Shizuko ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE 1; EPIDERMAL GROWTH FACTOR; PIOGLITAZONE; PLATELET DERIVED GROWTH FACTOR; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION PROFILING; GENE PRODUCT; GENETIC ANALYSIS; IMMUNOHISTOCHEMISTRY; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 84862290910     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/695898     Document Type: Article

References (45)

1. Grantham J. J., Mulamalla S., Swenson-Fields K. I., Why kidneys fail in autosomal dominant polycystic kidney disease Nature Reviews Nephrology 2011 7 10 556 566
2. Torres V. E., Harris P. C., Pirson Y., Autosomal dominant polycystic kidney disease Lancet 2007 369 9569 1287 1301 (Pubitemid 46552051)
3. Harris P. C., 2008 Homer W. Smith award: insights into the pathogenesis of polycystic kidney disease from gene discovery Journal of the American Society of Nephrology 2009 20 6 1188 1198
4. Sweeney W. E. Jr, Avner E. D., Diagnosis and management of childhood polycystic kidney disease Pediatric Nephrology 2011 26 5 675 692
5. Turkbey B., Ocak I., Daryanani K., Font-Montgomery E., Lukose L., Bryant J., Tuchman M., Mohan P., Heller T., Gahl W. A., Choyke P. L., Gunay-Aygun M., Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD/CHF) Pediatric Radiology 2009 39 2 100 111
6. Yessoufou A., Wahli W., Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels Swiss Medical Weekly 2010 140 13071 4 10
7. Nofziger C., Blazer-Yost B. L., PPAR agonists, modulation of ion transporters, and fluid retention Journal of the American Society of Nephrology 2009 20 12 2481 2483
8. Muto S., Aiba A., Saito Y., Nakao K., Nakamura K., Tomita K., Kitamura T., Kurabayashi M., Nagai R., Higashihara E., Harris P. C., Katsuki M., Horie S., Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant Human Molecular Genetics 2002 11 15 1731 1742 (Pubitemid 34812094)
9. Dai B., Liu Y., Mei C., Fu L., Xiong X., Zhang Y., Shen X., Hua Z., Rosiglitazone attenuates development of polycystic kidney disease and prolongs survival in Han:SPRD rats Clinical Science 2010 119 8 323 333
10. Yoshihara D., Kurahashi H., Morita M., Kugita M., Hiki Y., Aukema H. M., Yamaguchi T., Calvet J. P., Wallace D. P., Nagao S., PPAR-γ agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease American Journal of Physiology 2011 300 2 F465 F474
11. Kugita M., Nishii K., Morita M., Yoshihara D., Kowa-Sugiyama H., Yamada K., Yamaguchi T., Wallace D. P., Calvet J. P., Kurahashi H., Nagao S., Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling American Journal of Physiology 2011 300 1 F177 F188
12. Subramanian A., Tamayo P., Mootha V. K., Mukherjee S., Ebert B. L., Gillette M. A., Paulovich A., Pomeroy S. L., Golub T. R., Lander E. S., Mesirov J. P., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proceedings of the National Academy of Sciences of the United States of America 2005 102 43 15545 15550 (Pubitemid 41528093)
13. Ogata H., Goto S., Sato K., Fujibuchi W., Bono H., Kanehisa M., KEGG: kyoto encyclopedia of genes and genomes Nucleic Acids Research 1999 27 1 29 34 (Pubitemid 29209394)
14. Arozal W., Watanabe K., Veeraveedu P. T., Ma M., Thandavarayan R. A., Sukumaran V., Suzuki K., Kodama M., Aizawa Y., Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions Toxicology 2011 279 13 91 99
15. Chang M. Y., Ong A. C., Endothelin in polycystic kidney disease Contributions to Nephrology 2011 172 200 209
16. Igal R. A., Stearoyl-coa desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer Carcinogenesis 2010 31 9 1509 1515
17. Hess D., Chisholm J. W., Igal R. A., Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells PloS One 2010 5 6 e11394
18. Scaglia N., Chisholm J. W., Igal R. A., Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK PLoS ONE 2009 4 8
19. Yamaguchi T., Nagao S., Wallace D. P., Belibi F. A., Cowley B. D., Pelling J. C., Grantham J. J., Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys Kidney International 2003 63 6 1983 1994 (Pubitemid 36605809)
20. Nakamura T., Ebihara I., Nagaoka I., Tomino Y., Nagao S., Takahashi H., Koide H., Growth factor gene expression in kidney of murine polycystic kidney disease Journal of the American Society of Nephrology 1993 3 7 1378 1386
21. Nagao S., Yamaguchi T., Kusaka M., Maser R. L., Takahashi H., Cowley B. D., Grantham J. J., Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease Kidney International 2003 63 2 427 437 (Pubitemid 36126789)
22. Ibraghimov-Beskrovnaya O., Targeting dysregulated cell cycle and apoptosis for polycystic kidney disease therapy Cell Cycle 2007 6 7 776 779 (Pubitemid 46572612)
23. Nishio S., Hatano M., Nagata M., Horie S., Koike T., Tokuhisa T., Mochizuki T., Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation Journal of Clinical Investigation 2005 115 4 910 918 (Pubitemid 40489395)
24. Yu W., Kong T., Beaudry S., Tran M., Negoro H., Yanamadala V., Denker B. M., Polycystin-1 protein level determines activity of the G 12/JNK apoptosis pathway Journal of Biological Chemistry 2010 285 14 10243 10251
25. Yoshizawa K., Cioca D. P., Kawa S., Tanaka E., Kiyosawa K., Peroxisome proliferator-activated receptor ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines Cancer 2002 95 10 2243 2251 (Pubitemid 35253388)
26. Ming M., Yu J. P., Meng X. Z., Zhou Y. H., Yu H. G., Luo H. S., Effect of ligand troglitazone on peroxisome proliferator-activated receptor expression and cellular growth in human colon cancer cells World Journal of Gastroenterology 2006 12 45 7263 7270 (Pubitemid 44911830)
27. Cerquetti L., Sampaoli C., Amendola D., Bucci B., Masuelli L., Marchese R., Misiti S., De Venanzi A., Poggi M., Toscano V., Stigliano A., Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells Experimental Cell Research 2011 317 10 1397 1410
28. Liu Y., Dai B., Fu L., Jia J., Mei C., Rosiglitazone inhibits cell proliferation by inducing g1 cell cycle arrest and apoptosis in ADPKD cyst-lining epithelia cells Basic and Clinical Pharmacology and Toxicology 2010 106 6 523 530
29. Sagulenko E., Savelyeva L., Ehemann V., Sagulenko V., Hofmann W., Arnold K., Claas A., Scherneck S., Schwab M., Suppression of polyploidy by the BRCA2 protein Cancer Letters 2007 257 1 65 72 (Pubitemid 47464697)
30. Davenport J. W., Fernandes E. R., Harris L. D., Neale G. A. M., Goorha R., The mouse mitotic checkpoint gene Bub1b, a novel Bub1 family member, is expressed in a cell cycle-dependent manner Genomics 1999 55 1 113 117 (Pubitemid 29058901)
31. Myslinski E., Gérard M. A., Krol A., Carbon P., Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143 Nucleic Acids Research 2007 35 10 3453 3464 (Pubitemid 47073606)
32. Sengupta S., Nie J., Wagner R. J., Yang C., Stewart R., Thomson J. A., MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells Stem Cells 2009 27 7 1524 1528
33. Ullah Z., de Renty C., DePamphilis M. L., Checkpoint kinase 1 prevents cell cycle exit linked to terminal cell differentiation Molecular and Cellular Biology 2011 31 19 4129 4143
34. Wu D. T., Bitzer M., Ju W., Mundel P., Bttinger E. P., TGF- concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes Journal of the American Society of Nephrology 2005 16 11 3211 3221 (Pubitemid 46179327)
35. Degenhardt Y., Lampkin T., Targeting polo-like kinase in cancer therapy Clinical Cancer Research 2010 16 2 384 389
36. Wahl P. R., Hir M. L., Vogetseder A., Arcaro A., Starke A., Waeckerle-Men Y., Serra A. L., Wuthrich R. P., Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease Nephrology 2007 12 4 357 363 (Pubitemid 47075420)
37. Jackowski S., Cell cycle regulation of membrane phospholipid metabolism Journal of Biological Chemistry 1996 271 34 20219 20222 (Pubitemid 26281781)
38. Siperstein M. D., Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth Journal of Lipid Research 1984 25 13 1462 1468 (Pubitemid 15169462)
39. Golfman L. S., Bakovic M., Vance D. E., Transcription of the CTP:Phosphocholine Cytidylyltransferase Gene Is Enhanced during the S Phase of the Cell Cycle Journal of Biological Chemistry 2001 276 47 43688 43692
40. Koga H., Selvendiran K., Sivakumar R., Yoshida T., Torimura T., Ueno T., Sata M., PPAR potentiates anticancer effects of gemcitabine on human pancreatic cancer cells International Journal of Oncology 2012 40 3 679 685
41. Takano S., Kubota T., Nishibori H., Hasegawa H., Ishii Y., Nitori N., Ochiai H., Okabayashi K., Kitagawa Y., Watanabe M., Kitajima M., Pioglitazone, a ligand for peroxisome proliferator-activated receptor- acts as an inhibitor of colon cancer liver metastasis Anticancer Research 2008 28 6 3593 3599
42. Yao-Borengasser A., Rassouli N., Varma V., Bodles A. M., Rasouli N., Unal R., Phanavanh B., Ranganathan G., McGehee R. E., Kern P. A., Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor- responsiveness Journal of Clinical Endocrinology and Metabolism 2008 93 11 4431 4439 (Pubitemid 352789544)
43. Mai K., Andres J., Bobbert T., Assmann A., Biedasek K., Diederich S., Graham I., Larson T. R., Pfeiffer A. F. H., Spranger J., Rosiglitazone increases fatty acid 9-desaturation and decreases elongase activity index in human skeletal muscle in vivo Metabolism 2012 61 1 108 116
44. Song J., Liu H., Ressom H. W., Tiwari S., Ecelbarger C. M., Chronic rosiglitazone therapy normalizes expression of ACE1, SCD1 and other genes in the kidney of obese zucker rats as determined by microarray analysis Experimental and Clinical Endocrinology and Diabetes 2008 116 6 315 325 (Pubitemid 351947860)
45. Blazer-Yost B. L., Haydon J., Eggleston-Gulyas T., Chen J. H., Wang X., Gattone V., Torres V. E., Pioglitazone attenuates cystic burden in the PCK rodent model of polycystic kidney disease PPAR Research 2010 2010 8